MSI Financial Services’s Achillion Pharmaceuticals ACHN Stock Holding History

MSI Financial Services’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$32K	Hold	7,800	–	–	﹤0.01%	2137
2016 Q3	$63K	Hold	7,800	–	–	﹤0.01%	1696
2016 Q2	$61K	Hold	7,800	–	–	﹤0.01%	1711
2016 Q1	$60K	Hold	7,800	–	–	﹤0.01%	1626
2015 Q4	$84K	Buy	7,800 +800	+11%	+$7.27K	﹤0.01%	1384
2015 Q3	$48K	Hold	7,000	–	–	﹤0.01%	1239
2015 Q2	$62K	Hold	7,000	–	–	﹤0.01%	1198
2015 Q1	$69K	Buy	+7,000	New	+$87.4K	﹤0.01%	1168

Other funds holding ACHN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

MSI Financial Services's ACHN Position: Q4 2016 in Review

MSI Financial Services held its Achillion Pharmaceuticals (ACHN) position steady in Q4 2016 at 7,800 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #2137.

MSI Financial Services first reported a position in ACHN in Q1 2015 and has held it in 8 quarters since. The position peaked at $84K in Q4 2015. 140 funds tracked by Wall St. Rank hold ACHN as of Q4 2016.

MSI Financial Services held 7,800 shares of Achillion Pharmaceuticals worth $32K as of Q4 2016.
MSI Financial Services left its Achillion Pharmaceuticals share count unchanged in Q4 2016.
Achillion Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2137 holding.
MSI Financial Services first reported a position in Achillion Pharmaceuticals in Q1 2015 and has held it in 8 quarters since.
MSI Financial Services's Achillion Pharmaceuticals position peaked at $84K in Q4 2015.
140 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.